JesseWadeKellerMDMPHS

Oncology • Saint Louis, MO

Hematologic Oncology

Assistant Professsor, Washington University School of Medicine

Join to view full profile

Dr. Keller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Keller's full profile

Already have an account?

Office
10 Barnes West Dr
# Dv
Saint Louis, MO 63141
Phone+1 800-647-2098

Fax+1 314-362-3192

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2014 - 2016
Johns Hopkins University School of MedicineClass of 2009

Certifications & Licensure

CA State Medical License 2010 - Present
IL State Medical License 2020 - 2026
MO State Medical License 2013 - 2025
OK State Medical License 2024 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

2 citations
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
Shamia Hoque, Brian J. Chen, Martin W. Schoen, Kenneth R. Carson, Jesse Keller
Plos One. 2020-06-25
12 citations
Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma
Theodore S. Thomas, Suhong Luo, Patrick M. Reagan, Jesse Keller, Kristen M. Sanfilippo
Journal of Geriatric Oncology. 2020-01-01
103 citations
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
Kristen M. Sanfilippo, Suhong Luo, Tzu-Fei Wang, Mark A. Fiala, Martin W. Schoen
American Journal of Hematology. 2019-11-01

Lectures

Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018